In yesterday’s Wall Street session, Rockwell Medical Inc. (NASDAQ:RMTI) shares traded at $3.58, up 6.87% from the previous session.
As of this writing, 1 analysts cover Rockwell Medical Inc. (NASDAQ:RMTI). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $11.00 and a low of $11.00, we find $11.00. Given the previous closing price of $3.35, this indicates a potential upside of 228.36 percent. RMTI stock price is now -11.31% away from the 50-day moving average and 62.76% away from the 200-day moving average. The market capitalization of the company currently stands at $95.41M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
There are 0 analysts who have given it a hold rating, whereas 1 have given it a buy rating. Brokers who have rated the stock have averaged $11.00 as their price target over the next twelve months.
With the price target of $10, Piper Jaffray recently initiated with Overweight rating for Rockwell Medical Inc. (NASDAQ: RMTI).
A total of 5.58% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in RMTI stock. A new stake in Rockwell Medical Inc. shares was purchased by STRATOS WEALTH PARTNERS, LTD. during the first quarter worth $538,000. VIRTU FINANCIAL LLC invested $115,000 in shares of RMTI during the first quarter. In the first quarter, SIGMA PLANNING CORP acquired a new stake in Rockwell Medical Inc. valued at approximately $90,000. NUVEEN ASSET MANAGEMENT, LLC acquired a new stake in RMTI for approximately $65,000. AMERITAS ADVISORY SERVICES, LLC purchased a new stake in RMTI valued at around $38,000 in the second quarter. In total, there are 43 active investors with 22.30% ownership of the company’s stock.
Friday morning saw Rockwell Medical Inc. (NASDAQ: RMTI) opened at $3.3600. During the past 12 months, Rockwell Medical Inc. has had a low of $0.84 and a high of $6.24. As of last week, the company has a debt-to-equity ratio of 0.74, a current ratio of 2.00, and a quick ratio of 1.60. The fifty day moving average price for RMTI is $4.0614 and a two-hundred day moving average price translates $2.2115 for the stock.
The latest earnings results from Rockwell Medical Inc. (NASDAQ: RMTI) was released for Mar, 2023. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.1, beating analysts’ expectations of -$0.16 by 0.06. This compares to -$0.84 EPS in the same period last year. The net profit margin was -17.40% and return on equity was -84.30% for RMTI. The company reported revenue of $19.67 million for the quarter, compared to $16.12 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 21.98 percent. For the current quarter, analysts expect RMTI to generate $18.08M in revenue.
